Dapagliflozin Tetraacetate Reference Standard: Applications in Pharmaceutical Analysis
The quality, safety, and consistency of pharmaceutical products depend heavily on the ability to identify, characterize, and control impurities throughout drug development and commercial manufacturing. As analytical laboratories increasingly focus on trace-level impurities and sophisticated impurity profiling, reliable reference standards have become essential tools for method development, validation, quality control, and regulatory submissions.
Dapagliflozin Tetraacetate is an important analytical reference material associated with dapagliflozin impurity research. It can be used by pharmaceutical companies, contract research organizations (CROs), quality-control laboratories, and analytical development teams for the identification and evaluation of impurity-related peaks during pharmaceutical analysis.
Chemicea Pharmaceuticals offers Dapagliflozin Tetraacetate as an impurity reference standard under CAT. No. CP-D8006, with CAS No. 461432-25-7, molecular formula C29H33ClO10, and molecular weight 577.02 g/mol. The product is categorized by Chemicea as an impurity standard and is listed as in stock.
This article explores the analytical significance of Dapagliflozin Tetraacetate and its applications in pharmaceutical research, method development, impurity identification, validation, stability studies, and quality control.
What Is Dapagliflozin Tetraacetate?
Dapagliflozin Tetraacetate is an acetylated derivative associated with the dapagliflozin chemical structure. Chemicea identifies it by the synonym Dapagliflozin Tetraacetyl Impurity. Its chemical name is:
(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate.
The analytical identity of the compound is defined by its CAS number, molecular formula, molecular weight, and chemical structure, making a suitable reference material valuable for laboratories investigating dapagliflozin-related impurities.
Dapagliflozin itself is an established pharmaceutical compound, and Chemicea maintains a broader portfolio of dapagliflozin-related reference materials, including process impurities, degradation-related compounds, isomers, and other structurally related substances.
Product Information at a Glance
Parameter | Dapagliflozin Tetraacetate |
Product Name | Dapagliflozin Tetraacetate |
CAT. No. | CP-D8006 |
CAS No. | 461432-25-7 |
Molecular Formula | C29H33ClO10 |
Molecular Weight | 577.02 g/mol |
Category | Impurity Reference Standard |
Synonym | Dapagliflozin Tetraacetyl Impurity |
Application | Pharmaceutical analytical research |
The above product information is provided by Chemicea on its product page.
Why Reference Standards Are Important in Pharmaceutical Analysis
Reference standards provide laboratories with a defined analytical comparator against which unknown substances can be evaluated. In impurity analysis, this becomes particularly important because chromatographic peaks observed during testing cannot always be assigned confidently based only on retention time.
A characterized reference standard can help analysts establish the identity and analytical response of a specific impurity. This is particularly useful during:
HPLC and UPLC method development
Impurity profiling
Related-substance testing
Method validation
Stability-indicating method development
Forced degradation investigations
Process optimization
Quality-control testing
Regulatory documentation
For dapagliflozin products, laboratories may need to distinguish the active pharmaceutical ingredient from structurally related substances generated during synthesis, processing, storage, or analytical stress conditions.
Role of Dapagliflozin Tetraacetate in Method Development
Analytical method development is one of the most important stages in pharmaceutical development. The objective is to develop a method capable of adequately separating the API from its related substances and degradation products.
A Dapagliflozin Tetraacetate reference standard can be incorporated into method-development studies to investigate the chromatographic behavior of the compound.
For example, an analytical scientist may evaluate parameters such as:
Stationary-phase selection
Mobile-phase composition
Organic solvent ratio
Buffer concentration
pH
Column temperature
Flow rate
Injection volume
Detection wavelength
Gradient conditions
The reference standard provides an authentic analytical target for determining whether a chromatographic method can detect and distinguish the compound from dapagliflozin and other related substances.
This approach is particularly useful when developing high-resolution HPLC or UPLC methods intended for pharmaceutical quality assessment.
Applications in HPLC and UPLC Analysis
Liquid chromatography remains one of the primary techniques used for pharmaceutical impurity analysis. Dapagliflozin-related substances may exhibit similar chemical and chromatographic characteristics because of their structural relationship to the parent molecule.
A reference standard such as Dapagliflozin Tetraacetate can therefore assist analysts in establishing peak identity and evaluating chromatographic separation.
During method development, the reference material may be analyzed individually and alongside dapagliflozin API or pharmaceutical dosage-form samples. Comparing retention behavior and detector response can help analysts assign chromatographic peaks with greater confidence.
USP has also published proposed analytical procedures for dapagliflozin tablets involving liquid chromatography for assay and organic impurities testing, illustrating the importance of chromatographic approaches in dapagliflozin pharmaceutical analysis.
Supporting Analytical Method Validation
Once an analytical method has been developed, validation is required to demonstrate that it performs appropriately for its intended purpose.
Impurity reference standards can contribute to several validation characteristics, including:
Specificity
Specificity determines whether an analytical method can distinguish the analyte or impurity from other components in the sample matrix.
Dapagliflozin Tetraacetate can be used as an analytical challenge material to determine whether the method adequately separates the target compound from dapagliflozin and other related substances.
Precision
Precision evaluates the closeness of agreement between repeated measurements. Reference materials can support repeatability and intermediate-precision investigations by providing a consistent analytical target.
Accuracy
Where appropriate, impurity standards can be used in recovery studies to evaluate the accuracy of quantitative impurity determination.
Linearity
Multiple concentrations of a reference standard may be evaluated to establish detector response and assess the linearity of the analytical procedure over the intended concentration range.
Limit of Detection and Limit of Quantification
Reference standards are also useful when determining the sensitivity of an impurity method. Low-level solutions can help laboratories establish whether the method can reliably detect and quantify the target impurity at the required analytical concentration.
Use in Stability and Forced Degradation Studies
Stability studies are designed to understand how pharmaceutical substances and products behave under defined storage conditions over time. Forced degradation studies, meanwhile, deliberately expose an API or formulation to stress conditions to investigate potential degradation pathways.
Typical stress conditions can include:
Acidic hydrolysis
Basic hydrolysis
Oxidation
Thermal stress
Humidity
Photolytic stress
When degradation samples are analyzed, additional chromatographic peaks may appear. A suitable reference standard can help analysts determine whether a particular peak corresponds to a known related substance.
Dapagliflozin Tetraacetate may therefore be relevant when investigating the chromatographic profile of dapagliflozin-related materials and evaluating potential impurity peaks.
The use of authentic reference materials can strengthen peak-assignment studies and contribute to the development of stability-indicating analytical procedures.
Importance in Pharmaceutical Quality Control
Quality-control laboratories require reliable analytical procedures for the testing of APIs and finished pharmaceutical products. Impurity testing is an important part of this process because the presence of unwanted substances can affect pharmaceutical quality.
A reference standard can support routine QC activities by providing a material against which chromatographic responses can be compared.
Depending on the validated analytical procedure and intended application, Dapagliflozin Tetraacetate may be useful for:
Related-substance analysis
Impurity identification
System suitability investigations
Peak confirmation
Method verification
Batch-release testing
Stability sample analysis
The exact use and acceptance criteria should always be established according to the applicable validated analytical method and relevant regulatory requirements.
Supporting Regulatory and Documentation Requirements
Pharmaceutical manufacturers developing generic or innovator products must provide comprehensive analytical documentation demonstrating product quality and consistency.
Reference standards can play an important role in generating analytical evidence for regulatory submissions. They may be used during analytical method development and validation and for supporting impurity identification.
Chemicea's product page specifically identifies Dapagliflozin Tetraacetate for applications such as method validation, ANDA filing, forced degradation studies, identification standards, and DMF filing.
For pharmaceutical organizations preparing regulatory documentation, having access to appropriately characterized impurity standards can simplify analytical investigations and provide a reliable material for laboratory testing.
Chemicea's Dapagliflozin Impurity Reference Standards
Chemicea Pharmaceuticals maintains a dedicated portfolio of dapagliflozin-related reference materials. Its catalog includes the API as well as multiple related compounds, including Dapagliflozin Bromo Impurity, Dapagliflozin Impurity D, Dapagliflozin Impurity 3, Dapagliflozin deschloro impurity, Dapagliflozin desethoxy impurity, Dapagliflozin Furanose Isomer, and other specialized compounds.
This broader portfolio can be particularly valuable for laboratories conducting comprehensive impurity profiling rather than investigating a single compound in isolation.
Chemicea also lists certain dapagliflozin-related compounds as available through custom synthesis, providing an option when a required analytical material is not readily available as a standard catalog product.
Custom Synthesis for Specialized Analytical Requirements
Pharmaceutical research programs frequently encounter impurities or degradation products that are not commercially available in standard quantities. In such cases, custom synthesis can provide an important solution.
Chemicea's chemistry-focused capabilities support the development and synthesis of specialized pharmaceutical reference materials. Custom synthesis may be particularly relevant for:
Newly identified process impurities
Unknown degradation products
Novel metabolites
Route-specific impurities
Isomeric compounds
Specialized analytical markers
Stable-isotope-labeled compounds
For analytical development teams, this capability can help bridge the gap between impurity identification and availability of a suitable reference material.
Selection of a Reliable Reference Standard Supplier
When selecting a pharmaceutical reference standard supplier, laboratories should consider several factors beyond product availability. Important considerations include:
Accurate chemical identity
Appropriate characterization
Reliable documentation
Lot-specific analytical information
Traceability
Consistent supply
Technical support
Custom synthesis capability
Experience with pharmaceutical impurities
Global supply capabilities
Chemicea provides product documentation options such as COA and MSDS access through its product platform, allowing customers to obtain relevant documentation for analytical and laboratory requirements.
Dapagliflozin Tetraacetate and the Future of Pharmaceutical Impurity Analysis
As pharmaceutical analytical science continues to advance, laboratories are increasingly expected to detect and characterize impurities at increasingly low concentrations. Modern LC-MS, high-resolution mass spectrometry, NMR, and other advanced analytical technologies can provide detailed structural information, but reliable reference materials remain essential for confirming compound identity.
The combination of advanced instrumentation and high-quality reference standards enables analytical scientists to build more robust impurity profiles and improve confidence in peak assignment.
For dapagliflozin development and quality-control programs, a comprehensive library of related substances can provide additional analytical flexibility. Rather than relying exclusively on retention-time comparisons or theoretical degradation pathways, laboratories can compare samples against authentic reference materials.
Conclusion
Dapagliflozin Tetraacetate Reference Standard is a valuable analytical material for laboratories involved in dapagliflozin-related pharmaceutical research. With CAT. No. CP-D8006, CAS No. 461432-25-7, molecular formula C29H33ClO10, and molecular weight 577.02 g/mol, Chemicea lists the compound as an impurity reference standard and provides supporting documentation through its product platform.
Its potential applications span analytical method development, chromatographic peak identification, method validation, impurity profiling, forced degradation investigations, stability studies, quality-control testing, and regulatory analytical activities.
For pharmaceutical manufacturers and analytical laboratories, the availability of reliable dapagliflozin-related reference materials can improve the efficiency and confidence of analytical investigations. Chemicea's broader dapagliflozin impurity portfolio, together with its custom-synthesis capabilities, provides a useful resource for organizations requiring both established and specialized pharmaceutical reference standards.
As impurity control becomes an increasingly important component of pharmaceutical quality management, well-characterized reference standards will continue to serve as essential tools for analytical scientists working across drug development, manufacturing, quality control, and regulatory support.
Comments